AAAAAA

   
Results: 1-15 |
Results: 15
Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy
Authors: Ulrich-Pur, H Kornek, GV Fiebiger, W Gedlicka, C Raderer, M Lenauer, A Depisch, D Lang, F Pidlich, J Scheithauer, W
Citation: H. Ulrich-pur et al., Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy, ANN ONCOL, 12(9), 2001, pp. 1269-1272
Second-line treatment with oxaliplatin plus raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy
Authors: Scheithauer, W Kornek, GV Schuell, B Ulrich-Pur, H Penz, M Raderer, M Lang, F Schneeweiss, B Lenauer, A Depisch, D
Citation: W. Scheithauer et al., Second-line treatment with oxaliplatin plus raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy, ANN ONCOL, 12(5), 2001, pp. 709-714
Phase II trial of two-weekly gemcitabine in patients with advanced biliarytract cancer
Authors: Penz, M Kornek, GV Raderer, M Ulrich-Pur, H Fiebiger, W Lenauer, A Depisch, D Krauss, G Schneeweiss, B Scheithauer, W
Citation: M. Penz et al., Phase II trial of two-weekly gemcitabine in patients with advanced biliarytract cancer, ANN ONCOL, 12(2), 2001, pp. 183-186
Treatment of advanced breast cancer with vinorelbine and docetaxel with orwithout human granulocyte colony-stimulating factor
Authors: Kornek, GV Ulrich-Pur, H Penz, M Haider, K Kwasny, W Depisch, D Kovats, E Lang, F Schneeweiss, B Scheithauer, W
Citation: Gv. Kornek et al., Treatment of advanced breast cancer with vinorelbine and docetaxel with orwithout human granulocyte colony-stimulating factor, J CL ONCOL, 19(3), 2001, pp. 621-627
Expression of the lung resistance protein in primary colorectal carcinomas
Authors: Pohl, G Suchomel, RW Stranzl, T Depisch, D Stiglbauer, W Filipits, M Pirker, R
Citation: G. Pohl et al., Expression of the lung resistance protein in primary colorectal carcinomas, ANTICANC R, 21(1A), 2001, pp. 201-204
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial
Authors: Scheithauer, W Kornek, GV Ulrich-Pur, H Penz, M Raderer, M Salek, T Haider, K Kwasny, W Depisch, D
Citation: W. Scheithauer et al., Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial, CANCER, 91(7), 2001, pp. 1264-1271
Treatment of advanced, refractory breast cancer with alternating docetaxeland epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor
Authors: Kwasny, W Kornek, G Haider, K Valencak, J Ulrich-Pur, H Penz, M Lang, F Depisch, D Scheithauer, W
Citation: W. Kwasny et al., Treatment of advanced, refractory breast cancer with alternating docetaxeland epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor, BREAST CANC, 63(3), 2000, pp. 235-241
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma
Authors: Ulrich-Pur, H Kornek, GV Raderer, M Haider, K Kwasny, W Depisch, D Greul, R Schneeweiss, B Krauss, G Funovics, J Scheithauer, W
Citation: H. Ulrich-pur et al., A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma, CANCER, 88(11), 2000, pp. 2505-2511
Treatment of unresectable, locally advanced pancreatic adenocarcinoma withcombined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin
Authors: Kornek, GV Schratter-Sehn, A Marczell, A Depisch, D Karner, J Krauss, G Haider, K Kwasny, W Locker, G Scheithauer, W
Citation: Gv. Kornek et al., Treatment of unresectable, locally advanced pancreatic adenocarcinoma withcombined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin, BR J CANC, 82(1), 2000, pp. 98-103
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer
Authors: Scheithauer, W Kornek, GV Raderer, M Valencak, J Weinlander, G Hejna, M Haider, K Kwasny, W Depisch, D
Citation: W. Scheithauer et al., Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer, J CL ONCOL, 17(3), 1999, pp. 902-906
Expression of the multidrug resistance protein (MRP1) in breast cancer
Authors: Filipits, M Malayeri, R Suchomel, RW Pohl, G Stranzl, T Dekan, G Kaider, A Stiglbauer, W Depisch, D Pirker, R
Citation: M. Filipits et al., Expression of the multidrug resistance protein (MRP1) in breast cancer, ANTICANC R, 19(6B), 1999, pp. 5043-5049
Expression of the lung resistance protein (LRP) in primary breast cancer
Authors: Pohl, G Filipits, M Suchomel, RW Stranzl, T Depisch, D Pirker, R
Citation: G. Pohl et al., Expression of the lung resistance protein (LRP) in primary breast cancer, ANTICANC R, 19(6B), 1999, pp. 5051-5055
Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor
Authors: Haider, K Kornek, GV Kwasny, W Weinlander, G Valencak, J Lang, F Puribauer, F Kovats, E Depisch, D Scheithauer, W
Citation: K. Haider et al., Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor, BREAST CANC, 55(3), 1999, pp. 203-211
Coincidence of Crohn's disease and a high-risk gastrointestinal stromal tumor of the terminal ileum
Authors: Pfeffel, F Stiglbauer, W Depisch, D Oberhuber, G Raderer, M Scheithauer, W
Citation: F. Pfeffel et al., Coincidence of Crohn's disease and a high-risk gastrointestinal stromal tumor of the terminal ileum, DIGESTION, 60(4), 1999, pp. 363-366
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma
Authors: Scheithauer, W Kornek, GV Raderer, M Hejna, M Valencak, J Miholic, J Kovats, E Lang, F Funovics, J Bareck, E Depisch, D
Citation: W. Scheithauer et al., Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma, BR J CANC, 80(11), 1999, pp. 1797-1802
Risultati: 1-15 |